IRIS UniCatt

Bria, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.057
EU - Europa 6.101
AS - Asia 4.421
SA - Sud America 842
Continente sconosciuto - Info sul continente non disponibili 153
AF - Africa 116
OC - Oceania 31
Totale 19.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.764
DE - Germania 2.171
SG - Singapore 2.040
CN - Cina 1.160
IT - Italia 969
SE - Svezia 732
BR - Brasile 672
UA - Ucraina 606
FR - Francia 554
VN - Vietnam 361
GB - Regno Unito 324
IE - Irlanda 203
IN - India 162
FI - Finlandia 142
ID - Indonesia 142
RU - Federazione Russa 128
CA - Canada 111
BD - Bangladesh 93
JP - Giappone 88
PL - Polonia 71
TR - Turchia 70
MX - Messico 64
HK - Hong Kong 55
AR - Argentina 52
NL - Olanda 50
AU - Australia 30
CO - Colombia 29
IQ - Iraq 29
ES - Italia 27
ZA - Sudafrica 27
BE - Belgio 26
EC - Ecuador 24
SA - Arabia Saudita 23
CI - Costa d'Avorio 22
IR - Iran 19
VE - Venezuela 19
KR - Corea 18
JM - Giamaica 17
PK - Pakistan 17
MA - Marocco 16
IL - Israele 15
TT - Trinidad e Tobago 15
CR - Costa Rica 14
EG - Egitto 14
PY - Paraguay 14
CH - Svizzera 13
AT - Austria 12
CL - Cile 12
GP - Guadalupe 12
PE - Perù 12
PH - Filippine 12
HN - Honduras 11
LT - Lituania 11
NI - Nicaragua 11
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
NP - Nepal 9
TW - Taiwan 9
UZ - Uzbekistan 9
JO - Giordania 8
MY - Malesia 8
SV - El Salvador 8
TN - Tunisia 8
BG - Bulgaria 7
BY - Bielorussia 7
LB - Libano 7
TH - Thailandia 7
AL - Albania 6
DZ - Algeria 6
GE - Georgia 6
PR - Porto Rico 6
RO - Romania 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
NO - Norvegia 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
UY - Uruguay 5
GT - Guatemala 4
LK - Sri Lanka 4
A1 - Anonimo 3
BS - Bahamas 3
EE - Estonia 3
ET - Etiopia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
PS - Palestinian Territory 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 19.539
Salva come PNG Salva come JPEG
Città #
Ashburn 1.195
Singapore 1.120
Chandler 861
San Jose 641
Jacksonville 334
San Mateo 245
Dublin 198
Beijing 190
Milan 187
Nanjing 183
Wilmington 159
New York 144
Los Angeles 137
Nürnberg 124
Ho Chi Minh City 123
Dearborn 121
Jakarta 121
Woodbridge 120
Rome 119
Bremen 106
Houston 105
Lauterbourg 103
Hanoi 101
Hefei 91
Redwood City 90
Boston 87
Ann Arbor 77
Nanchang 77
Seattle 75
São Paulo 75
Council Bluffs 74
Moscow 69
Frankfurt am Main 68
Lawrence 68
Tokyo 67
Santa Clara 60
Munich 54
University Park 53
Phoenix 51
Dallas 50
Marseille 48
Princeton 48
Hong Kong 47
Norwalk 46
Buffalo 44
Mountain View 44
Lancaster 43
Paris 42
Atlanta 39
Brooklyn 37
Fairfield 36
Boardman 35
Philadelphia 35
Hebei 33
Kent 33
Cattolica 31
Guangzhou 30
Kunming 30
Shanghai 30
Warsaw 30
Chicago 28
North Bergen 28
Shenyang 28
Tianjin 27
Cambridge 26
Fremont 26
Hangzhou 26
Izmir 25
Abidjan 22
Changsha 22
Columbus 22
Falls Church 22
Helsinki 22
Kraków 22
Chennai 21
Orem 21
Rio de Janeiro 21
Toronto 21
Andover 20
Da Nang 20
Düsseldorf 20
London 20
Brussels 19
Mexico City 19
Montreal 19
Bologna 18
Porto Alegre 18
The Dalles 18
Memphis 17
Menlo Park 17
Naples 17
Jiaxing 16
San Francisco 16
Belo Horizonte 15
Detroit 15
Haiphong 15
Pune 15
Stockholm 15
Augusta 14
Baghdad 14
Totale 9.491
Salva come PNG Salva come JPEG
Nome #
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 386
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 307
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 306
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 277
Plasma cortisol levels and resilience in depressed patients 275
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 270
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 263
Neuroendocrinologia dei disturbi dell umore 261
Cognitive markers of psychotic unipolar depression: A meta-analytic study 260
Plasma magnesium level and psychomotor retardation in major depressed patients 246
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 246
Dopamine transporter availability and psychomotor retardation in major depression 240
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 234
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 228
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 223
Predicting treatment outcome in difficult-to-treat depressed patients 220
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 220
Plasma magnesium levels and treatment outcome in depressed patients 210
Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation 209
Problematic mobile phone use in adolescence: A cross-sectional study 208
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 207
Sexual Behavior in Women with Bipolar Disorder 206
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 205
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 205
A day treatment programme on mood disorders: One-year activity outcomes 203
Treatment of prurigo nodularis with pregabalin. 199
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 199
Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms 196
Alcohol protracted withdrawal syndrome: the role of anhedonia 194
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients 193
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 193
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 190
An observational study evaluating comorbidity between bipolar disorder and personality disorders 189
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 189
Internet addiction: hours spent online, behaviors and psychological symptoms 186
Il trattamento della schizofrenia 185
Anhedonia and Cortisol Levels in Major Depression. 184
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 183
Plasma magnesium levels and treatment outcome in depressed patients 182
Cognitive markers of psychotic unipolar depression: A meta-analytic study 180
Oxcarbazepine in bipolar disorder: a critical review of the literature 175
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 175
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 174
Hyperactivation of inflammatory response in depressed patients with psychomotor retardation 172
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 172
Changing of dopamine transporter binding in depressed patients with anhedonia during treatment 171
Striatal dopamine transporter density in anhedonic depressed patients before and after pharmachological treatment 171
Behavioural addictions in adolescents and young adults: results from a prevalence study. 170
Psicopatologia nell’epilessia e nella pseudoepilessia: risultati preliminari nella nostra esperienza 167
Behavioural addictions in adolescents and young adults: results from a prevalence study 167
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 167
Somatic symptoms and high-sensitive C-reactive protein in major depression 166
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 164
What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? 163
Mood, hormones and quality of life. 161
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 161
Analisi antropofenomenologica di un'esperienza in un'istituzione manicomiale del meridione 159
Treatment of prurigo nodularis with pregabalin 159
Oxcarbazepine improves mood in patients with epilepsy 158
Predictive value of magnesium levels in depressed patients. 158
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 158
Depression and suicide in epilepsy: Fact or artefact? 156
Enhanced BDNF serum levels in patients with severe pathological gambling 156
La gestione della crisi suicidaria: dall'emergenza clinica alla riabilitazione del paziente 156
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 156
Enhanced BDNF serum levels in patients with severe pathological gambling 156
Cocaine use disorders and serum magnesium profile 155
Facial emotion recognition deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease 154
Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder 153
Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders 153
Sleep Disturbances and Depression: a review 152
Duloxetine for premenstrual dysphoric disorder: a pilot study 152
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 150
Evidenze preliminari sulle modifiche del transporter della dopamina in pazienti depressi con rallentamento psicomotorio 150
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. 148
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 147
Major depressive disorder and dopamine transporter density: investigation by 123I-FP-CIT SPET 147
Ansia, depressione ed epilessia del lobo temporale 146
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. 146
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 145
Venlafaxine: Successful treatment in impulsive disorders 144
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers 143
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. 142
Inflammatory response and psychopathological dimensions in major depression 142
Neuroendocrinology of mood disorders. 141
Oxcarbazepine improves mood in patients with epilepsy. 139
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. 134
Valutazione dell esperienza di un gruppo di self-help in pazienti depressi in remissione parziale. 134
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions 132
Il self-help nelle condizioni depressive: analisi dell esperienza di un gruppo di mutuo-aiuto per pazienti depressi in remissione parziale. 131
Functional neuroimaging: points of intersection between biology and psychotherapy. 129
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 128
Reply to Dr Korczyn. 125
Relating with migrants: ethnopsychiatry and psychotherapy 122
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 122
Efficacy and safety of pregabalin in alcohol dependence 121
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. 121
Epilepsy and depression: risk factors for suicide? 121
Reply to Dr Corrao and colleagues. 119
Thalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles. 119
Totale 17.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022778 0 0 0 0 40 26 34 193 40 70 169 206
2022/20232.407 297 362 160 409 196 273 121 161 297 22 74 35
2023/20241.003 48 303 23 44 37 112 42 34 35 51 154 120
2024/20252.265 120 108 159 117 208 90 49 149 351 189 388 337
2025/20265.286 807 132 290 540 985 262 901 276 340 432 190 131
2026/20271.875 228 183 472 869 123 0 0 0 0 0 0 0
Totale 19.721